MedAware Systems International, Inc.

Biomed Industries, Inc. (Biomed) announced results today from its Phase 1B clinical trial of NA-831 for the treatment of Major Depressive Disorder (MDD).

Biomed Industries, Inc. (Biomed) announced today that it has entered into an Engagement Agreement with JP Morgan Securities, LLC to serve as its exclusive financial advisor for a potential acquisition of the Company.

Biomed Industries, Inc. (BIOMED) announced today that its recent acquisition of Boulder CO based MedAware Systems, Inc. is now complete. MedAware Systems will be integrated into the Company's AI subsidiary, Biomed AI Inc.

MedAware Systems announced today that it has added a new Sentiment Tracking feature to its Social Media Event Monitoring application for Medical Devices.

MedAware Systems announced today a major expansion of Neuromodulation device data in its SOHInfo customer portal (www.sohinfo.com.) The portal is populated with reported data from registries, published literature, and social media for all registered...

MedAware Systems announces that its Science of Health Informatics (SOHInfo) Post Market Surveillance Service for Catheter Introducer devices is now available.

MedAware Systems announced the release today of its Science of Health Informatics (SOHInfo) cross-platform monitoring and surveillance management service.

MedAware Systems announces that its Science of Health Informatics (SOHInfo) Post Market Surveillance Service for Cervical Disc Replacement devices is now available.

MedAware Systems' Science of Health Informatics (SOHInfo) announces a major upgrade of its medical device surveillance service to include reporting on social media posts.

MedAware Systems' Science of Health Informatics (SOHInfo) announces the launch of its comprehensive AI-powered surveillance service for Spinal Cord and Peripheral Nerve stimulation devices from all major manufacturers.